RBCL (RBC Life Sciences) Forward Dividend Yield %: 0.00% (As of Jun. 26, 2026)


What is RBC Life Sciences Forward Dividend Yield %?

RBC Life Sciences RBCL +0.14% Forward Dividend Yield % is 0.00% as of Jun. 26, 2026.

As of today (2026-06-26), the Forward Annual Dividend Yield of RBC Life Sciences is 0.00%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of RBC Life Sciences is 0.00%.

RBCL's Forward Dividend Yield % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.1
* Ranked among companies with meaningful Forward Dividend Yield % only.

RBC Life Sciences's Dividends per Share for the three months ended in Jun. 2017 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

RBC Life Sciences  (OTCPK:RBCL) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

RBC Life Sciences Forward Dividend Yield % Related Terms

RBCL vs SKVI, TISUQ, TECR: Forward Dividend Yield % Comparison

For the Household & Personal Products subindustry, RBC Life Sciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Life Sciences Forward Dividend Yield % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where RBC Life Sciences's Forward Dividend Yield % falls into.


RBC Life Sciences Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
RBC Life Sciences (RBCL) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Forward Dividend Yield % too high?
RBC Life Sciences' current Forward Dividend Yield % is 0.00%.
How does RBC Life Sciences' Forward Dividend Yield % compare to SKVI and TISUQ?
RBC Life Sciences' Forward Dividend Yield % of 0.00% can be compared against companies in the Consumer Packaged Goods industry. The industry median Forward Dividend Yield % is 3.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Consumer Packaged Goods company?
The median Forward Dividend Yield % among Consumer Packaged Goods companies is 3.10, based on 1,156 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on RBC Life Sciences and its competitors. For the Consumer Packaged Goods industry, the median Forward Dividend Yield % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RBC Life Sciences's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.